Name: Name:4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline
Brand: AABLOCKS
SKU: AA00IHP2
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA00IHP2

Chemical Name: 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline

CAS Number: 937263-71-3

Molecular Formula: C13H12N4O

Molecular Weight: 240.2606

MDL Number: MFCD28977540

SMILES: Nc1ccc(c(c1)C)Oc1ccn2c(c1)ncn2

Properties

Downstream Synthesis Route

937263-71-3

1429755-57-6

1429755-58-7

[1]CurrentPatentAssignee:PFIZERINC-WO2013/142875,2013,A1Locationinpatent:Paragraph00152

[2]CurrentPatentAssignee:PFIZERINC-WO2013/56108,2013,A2Locationinpatent:Paragraph000140

[3]CurrentPatentAssignee:PFIZERINC-US9457093,2016,B2Locationinpatent:Page/Pagecolumn22

[4]DeVries,Peter;Forero-Torres,Andres;Kulukian,Anita;Lee,Patrice;Peterson,Scott;Rosler,Robert;Taylor,Janelle;Watson,Daniel[MolecularCancerTherapeutics,2020,vol.19,#4,p.976-987]

99-53-6

937263-71-3

[1]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN109942576,2019,A

[2]CurrentPatentAssignee:SHANGHAIPHARMACEUTICALSHOLDINGCOMPANYLIMITED-US2020/190091,2020,A1

[3]Bu,Lehao;Chen,Wenxin;Liu,Yaowei;Mao,Yongjun;Yin,Lingfeng;Zhang,Long[Synthesis,2019,vol.51,#13,p.2660-2664]

[4]CurrentPatentAssignee:BLACKDIAMONDTHERAPEUTICSINC-WO2021/30711,2021,A1

[5]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-EP3792263,2021,A1

[6]CurrentPatentAssignee:WUHANNINEZHOULUSTUMEDICINESCIENCEANDTECHLIMITEDCOMPANY-CN114230568,2022,A

[7]CurrentPatentAssignee:ENLIVENTHERAPEUTICS-WO2022/6386,2022,A1

[8]CurrentPatentAssignee:SHANDONGJINCHENGPHARMACEUTICAL&CHEMICALCO.,LTD.-CN114031619,2022,A

65370-42-5

4-(1,2,4triazolo1,5-αpyridin-7-yloxy)-3-methylaniline

[1]Patent:CN109942576,2019,A

864244-98-4

937263-71-3

[1]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN109942576,2019,A

[2]CurrentPatentAssignee:SHANGHAIPHARMACEUTICALSHOLDINGCOMPANYLIMITED-US2020/190091,2020,A1

[3]Bu,Lehao;Chen,Wenxin;Liu,Yaowei;Mao,Yongjun;Yin,Lingfeng;Zhang,Long[Synthesis,2019,vol.51,#13,p.2660-2664]

[4]CurrentPatentAssignee:NINGBOYAOTENGPHARMACEUTICALTECH-CN111825604,2020,A

[5]CurrentPatentAssignee:BLACKDIAMONDTHERAPEUTICSINC-WO2021/30711,2021,A1

[6]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-EP3792263,2021,A1

[7]CurrentPatentAssignee:ENLIVENTHERAPEUTICS-WO2022/6386,2022,A1

N-hydroxy-N'-(4-(2-methyl-4-nitrophenoxy)pyridin-2-yl)formimidamide

937263-71-3

[1]CurrentPatentAssignee:SHANGHAIUNIVERSITYOFENGINEERINGSCIENCES-CN109942576,2019,A

[2]Bu,Lehao;Chen,Wenxin;Liu,Yaowei;Mao,Yongjun;Yin,Lingfeng;Zhang,Long[Synthesis,2019,vol.51,#13,p.2660-2664]

[3]CurrentPatentAssignee:WUXIAPPTECCO.,LTD.-EP3792263,2021,A1

937263-71-3 | 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline